Cardiac POC Testing Market Size, Trends and Insights By Product Type (Cardiac Markers Test, Analyzers, Others), By End User (Research Laboratories, Hospitals, Ambulatory Surgical Centres, Diagnostic Laboratories, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- LifeSign LLC
- Medtronic plc
- Nano-Ditech Corporation
- Nexus Dx Inc.
- Others
Reports Description
According to Custom Market Insights (CMI), The Global Cardiac POC Testing Market size was estimated at USD 1.2 billion in 2021 and is expected to reach USD 1.7 billion in 2022 and is expected to hit around USD 2.89 billion by 2030, poised to grow at a compound annual growth rate (CAGR) of 6.5% from 2022 to 2030.
Cardiac POC testing is a diagnostic test primarily related to the heart and carried out at or near the patient’s point of care.
POC testing is a blood diagnostic test used to detect cholesterol and blood coagulation in the body. This diagnostic test helps physicians to examine the risk of developing thrombosis and clotting inside a blood vessel, which leads to cardiac arrest.
Furthermore, cardiac POC testing involves troponin and brain natriuretic peptide analysis tests to identify cardiovascular disorders such as myocardial infarction, coronary artery disease, and heart failure. The Cardiac POC test is time practical. For instance, in most cases, diagnosis reports are provided within an hour after the submission of test samples. Thus, cardiac POC tests help reduce the turnaround time, allowing instant patient response and effective management of cardiac diseases.
Growth Factors.
The growing use of cardiac POC testing in hospitals and laboratories will aid market growth.
Increasing heart-related disorders among people will drive cardiac POC testing thus, increases the overall potential sale of POC testing across the globe. For instance, according to an article published by the National Medicine Library in July 2020, Ischemic Heart Disease (IHD )affects around 126 million individuals (1,655 per 100,000), which is approximately 1.72% of the world’s population. Therefore, the overall demand for the cardiac POIC testing market is expected to grow exponentially.
In response to this, the rising death of people due to coronary artery-related disease has become a significant concern among people, where cardiac POC testing device has gained popularity owing to their ease of operation and precise and quick results. However, another critical factor impeding market expansion is the strict regulatory requirements for approving new devices related to cardiac POC testing.
Furthermore, the adoption of sensitivity and premium-priced POC Troponin tests contributes to the growth of the global cardiac POC testing market. In addition, the growing move towards value-based and efficient healthcare service delivery against stringent budgets is boosting the prospects for POC Cardiac testing market. Moreover, several physicians opt for cardiac POC testing devices due to their quick monitoring and ease of the operating procedure. In response, the growing awareness of good health and the rapid shift in the healthy lifestyle has increased the consumer’s purchasing power in the medical field. These factors are anticipated to enhance the overall demand for cardiac POC testing market during the forecast period, thus, offering the most lucrative opportunities.
Cardiac POC testing market segmentation.
Cardiac POC testing Market, segmented by Type
Depending upon the types, the cardiac POC testing market is segmented into cardiac markers tests and analyzers.
The cardiac biomarker test segment dominated the market in 2021 and is expected to grow over the forecast period. The cardiac biomarker test involves measuring the levels of cardiac biomarkers in blood. These markers include enzymes, hormones, and proteins. In addition, these biomarker tests help detect the presence of ACS and cardiac ischemia and evaluate their severity. It is mainly used in the early prediction of heart dysfunction, due to which the demand for cardiac markers-based cardiac POC testing devices has captured the overall market share and escalated the need for cardiac POC testing during the forecast period.
Furthermore, the analyzer segment is expected to show a significant growth rate during the forecast period. Cardiac analyzers are also identified as
cardiac reader system that provides high throughput point-of-care solutions for the diagnosis of myocardial infarction and other cardiac-related diseases by measuring levels of STAT, cardiac troponin, CKM and CKB, myoglobin, and D-dimer in approximately as low as 14 minutes; equivalent to 36 tests per hour. In addition, a cardiac analyzer can accomplish these tests through immune-chromatographic assays and cardiac POC testing devices, owing to its efficiency and accuracy with advanced software solutions have boosted the market growth in upcoming years.
Cardiac POC testing market, segment based on End User
The global cardiac POC testing market is studied across research laboratories, hospitals, ambulatory surgical centers, and diagnostic laboratories. It is expected that the worldwide hospital end-user segment to hold a dominant position during 2022 -2031.
Hospitals’ end-user segment dominates the cardiac POC testing market and is expected to remain dominant during the forecast period. Cardiac POC testing is a high-performance, effective device with easy operation, accuracy, and quick results. Owing to these factors, cardiac POC testing has been used extensively in multispecialty and tertiary care hospitals. These factors are escalating the growth of the cardiac POC testing market.
Furthermore, the research and laboratory and diagnostic laboratories segment are expected to create the most lucrative application for the cardiac POC testing market. The demand for cardiac POC testing is increasing owing to consumers increasing demand for various heart-related pretests to avoid serious health issues; in addition, several key companies offer cardiac POC testing in multiple laboratories at a low price compared to hospitals’ cardiac POC testing.
Report Scope
| Feature of the Report | Details |
| Market Size in 2021 | USD 1.2 Billion |
| Projected Market Size in 2030 | USD 2.89 Billion |
| CAGR Growth Rate | 6.5% CAGR (2022-2030) |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Prominent Players | LifeSign LLC, Medtronic plc, Nano-Ditech Corporation, Nexus Dx Inc., PTS Diagnostics, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Nova Biomedical Corporation, Trividia Health Inc., Sekisui Diagnostics, Nipro Corp., Trinity Biotech, Orasure Technologies, Inc., Spectral Medical Inc, and Others |
| Key Segment | By Product Type, End User, and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfill your requirements for research. |
Regional Insights
Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
Asia-Pacific is the dominant region in the cardiac POC testing market. The utilization of cardiac POC testing has increased in the sectors such as hospitals, laboratories, diagnostic centers, and other key market trends in the Asia-Pacific region. In addition, the rise in the population, associated with high susceptibility to chronic diseases related to cardiac disorders, and economical diagnosis of chronic diseases in rural areas are expected to boost the global market growth in the Asia-Pacific region.
The cardiac POC testing devices market in the Asia Pacific is expected to experience rapid growth over the forecast period due to the growing population and increasing purchasing power of patients, an increase in the number of tests during a pandemic, and growing awareness of people about heart-related health issues has made them more linear towards purchasing or opting for cardiac POC testing. These factors are projected to enhance the cardiac POC testing market demand in the upcoming years.
Moreover, China and Japan is the topmost producer of a medical device in the world where cardiac POC testing is widely employed in medical, hospitals, diagnostic centers, and many others due to rising obesity among people, an increase in heart-related issues, and an increase in the number of cardiac POC testing has increased the potential sales of cardiac POC testing market. These factors are escalating the demand for cardiac POC testing in Asia-Pacific.
Also, the region has well established medical sector where demand for cardiac POC testing has increased.
The Europe and North American regions are also anticipated to maintain dominance throughout the forecast period. Countries such as the U.S., Canada, and Mexico significantly contribute to the growth of the cardiac POC testing market in the region. Critical factors for the change in the North American area are the growing population, an increase in the number of heart-related diseases, and government initiation and investment in the medical sector have provided the way for the growth of the cardiac POC testing market.
Key Players
- LifeSign LLC
- Medtronic plc
- Nano-Ditech Corporation
- Nexus Dx Inc.
- PTS Diagnostics
- Bio-Rad Laboratories Inc.
- Hoffmann-La Roche AG
- Nova Biomedical Corporation
- Trividia Health Inc.
- Sekisui Diagnostics
- Nipro Corp.
- Trinity Biotech
- Orasure Technologies, Inc.
- Spectral Medical Inc.
COVID-19 Analysis
The novel coronavirus is an incomparable global pandemic that has spread to over 180 countries and caused huge losses of lives and the economy around the globe. As a result, the guidelines and policies of the logistics and supply chain of the cardiac POC testing products were affected slightly. In the first quarter of 2020, reductions in diagnostic cardiovascular testing worldwide have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality.
In addition, the increase in the number of COVID patients, in turn, leads to more cardiac tests. Furthermore, several manufacturers have increased their production capacities for Cardiac POC testing devices to meet the growing demand.
In addition, as the restrictions imposed due to lockdowns are being lifted in the fourth quarter of the pandemic, healthcare, and pharmaceutical, among other sectors, is expected to recover soon owing to the record of cardiac POC testing production unit in both developed and developing economies.
Recent Developments
December 2021 – Thermo Fisher Scientific and Color Health collaborated to launch a k-12 reader check covid-19 testing solution for Texas schools.
July 2021 – Panbio COVID-19 Antigen Rapid Self-Test is a lateral flow assay for the rapid, qualitative detection of the SARS-CoV-2 virus. The test received CE Mark approval and is also approved by the ICMR advisory in India.
Segments covered in the report
By Product Type
- Cardiac Markers Test
- Analyzers
- Others
By End User
- Research Laboratories
- Hospitals
- Ambulatory Surgical Centres
- Diagnostic Laboratories
- Others
On the basis of Geography
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Cardiac POC Testing Market, (2022 – 2030) (USD Billion)
- 2.2 Global Cardiac POC Testing Market : snapshot
- Chapter 3. Global Cardiac POC Testing Market – Industry Analysis
- 3.1 Cardiac POC Testing Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Use Of Cardiac POC Testing In Hospitals And Laboratories
- 3.2.2 Increasing Heart-Related Disorders
- 3.2.3 Increases The Overall Potential Sale Of POC Testing
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Product Type
- 3.7.2 Market attractiveness analysis By End User
- Chapter 4. Global Cardiac POC Testing Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Cardiac POC Testing Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Cardiac POC Testing Market – Product Type Analysis
- 5.1 Global Cardiac POC Testing Market overview: By Product Type
- 5.1.1 Global Cardiac POC Testing Market share, By Product Type, 2021 and 2030
- 5.2 Cardiac Markers Test
- 5.2.1 Global Cardiac POC Testing Market by Cardiac Markers Test, 2022 – 2030 (USD Billion)
- 5.3 Analyzers
- 5.3.1 Global Cardiac POC Testing Market by Analyzers, 2022 – 2030 (USD Billion)
- 5.1 Global Cardiac POC Testing Market overview: By Product Type
- Chapter 6. Global Cardiac POC Testing Market – End User Analysis
- 6.1 Global Cardiac POC Testing Market overview: By End User
- 6.1.1 Global Cardiac POC Testing Market share, By End User, 2021 and 2030
- 6.2 Research Laboratories
- 6.2.1 Global Cardiac POC Testing Market by Research Laboratories, 2022 – 2030 (USD Billion)
- 6.3 Hospitals
- 6.3.1 Global Cardiac POC Testing Market by Hospitals, 2022 – 2030 (USD Billion)
- 6.4 Ambulatory Surgical Centres
- 6.4.1 Global Cardiac POC Testing Market by Ambulatory Surgical Centres, 2022 – 2030 (USD Billion)
- 6.5 Diagnostic Laboratories
- 6.5.1 Global Cardiac POC Testing Market by Diagnostic Laboratories, 2022 – 2030 (USD Billion)
- 6.1 Global Cardiac POC Testing Market overview: By End User
- Chapter 7. Cardiac POC Testing Market – Regional Analysis
- 7.1 Global Cardiac POC Testing Market Regional Overview
- 7.2 Global Cardiac POC Testing Market Share, by Region, 2021 & 2030 (USD Billion)
- 7.3. North America
- 7.3.1 North America Cardiac POC Testing Market, 2022 – 2030 (USD Billion)
- 7.3.1.1 North America Cardiac POC Testing Market, by Country, 2022 – 2030 (USD Billion)
- 7.3.1 North America Cardiac POC Testing Market, 2022 – 2030 (USD Billion)
- 7.4 North America Cardiac POC Testing Market, by Product Type, 2022 – 2030
- 7.4.1 North America Cardiac POC Testing Market, by Product Type, 2022 – 2030 (USD Billion)
- 7.5 North America Cardiac POC Testing Market, by End User, 2022 – 2030
- 7.5.1 North America Cardiac POC Testing Market, by End User, 2022 – 2030 (USD Billion)
- 7.6. Europe
- 7.6.1 Europe Cardiac POC Testing Market, 2022 – 2030 (USD Billion)
- 7.6.1.1 Europe Cardiac POC Testing Market, by Country, 2022 – 2030 (USD Billion)
- 7.6.1 Europe Cardiac POC Testing Market, 2022 – 2030 (USD Billion)
- 7.7 Europe Cardiac POC Testing Market, by Product Type, 2022 – 2030
- 7.7.1 Europe Cardiac POC Testing Market, by Product Type, 2022 – 2030 (USD Billion)
- 7.8 Europe Cardiac POC Testing Market, by End User, 2022 – 2030
- 7.8.1 Europe Cardiac POC Testing Market, by End User, 2022 – 2030 (USD Billion)
- 7.9. Asia Pacific
- 7.9.1 Asia Pacific Cardiac POC Testing Market, 2022 – 2030 (USD Billion)
- 7.9.1.1 Asia Pacific Cardiac POC Testing Market, by Country, 2022 – 2030 (USD Billion)
- 7.9.1 Asia Pacific Cardiac POC Testing Market, 2022 – 2030 (USD Billion)
- 7.10 Asia Pacific Cardiac POC Testing Market, by Product Type, 2022 – 2030
- 7.10.1 Asia Pacific Cardiac POC Testing Market, by Product Type, 2022 – 2030 (USD Billion)
- 7.11 Asia Pacific Cardiac POC Testing Market, by End User, 2022 – 2030
- 7.11.1 Asia Pacific Cardiac POC Testing Market, by End User, 2022 – 2030 (USD Billion)
- 7.12. Latin America
- 7.12.1 Latin America Cardiac POC Testing Market, 2022 – 2030 (USD Billion)
- 7.12.1.1 Latin America Cardiac POC Testing Market, by Country, 2022 – 2030 (USD Billion)
- 7.12.1 Latin America Cardiac POC Testing Market, 2022 – 2030 (USD Billion)
- 7.13 Latin America Cardiac POC Testing Market, by Product Type, 2022 – 2030
- 7.13.1 Latin America Cardiac POC Testing Market, by Product Type, 2022 – 2030 (USD Billion)
- 7.14 Latin America Cardiac POC Testing Market, by End User, 2022 – 2030
- 7.14.1 Latin America Cardiac POC Testing Market, by End User, 2022 – 2030 (USD Billion)
- 7.15. The Middle-East and Africa
- 7.15.1 The Middle-East and Africa Cardiac POC Testing Market, 2022 – 2030 (USD Billion)
- 7.15.1.1 The Middle-East and Africa Cardiac POC Testing Market, by Country, 2022 – 2030 (USD Billion)
- 7.15.1 The Middle-East and Africa Cardiac POC Testing Market, 2022 – 2030 (USD Billion)
- 7.16 The Middle-East and Africa Cardiac POC Testing Market, by Product Type, 2022 – 2030
- 7.16.1 The Middle-East and Africa Cardiac POC Testing Market, by Product Type, 2022 – 2030 (USD Billion)
- 7.17 The Middle-East and Africa Cardiac POC Testing Market, by End User, 2022 – 2030
- 7.17.1 The Middle-East and Africa Cardiac POC Testing Market, by End User, 2022 – 2030 (USD Billion)
- Chapter 8. Company Profiles
- 8.1 LifeSign LLC
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 Medtronic plc
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 Nano-Ditech Corporation
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 Nexus Dx Inc.
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 PTS Diagnostics
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 Bio-Rad Laboratories Inc.
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 F. Hoffmann-La Roche AG
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 Nova Biomedical Corporation
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 Trividia Health Inc.
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Sekisui Diagnostics
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 Nipro Corp.
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.12 Trinity Biotech
- 8.12.1 Overview
- 8.12.2 Financials
- 8.12.3 Product Portfolio
- 8.12.4 Business Strategy
- 8.12.5 Recent Developments
- 8.13 Orasure Technologies
- 8.13.1 Overview
- 8.13.2 Financials
- 8.13.3 Product Portfolio
- 8.13.4 Business Strategy
- 8.13.5 Recent Developments
- 8.15 Spectral Medical Inc
- 8.15.1 Overview
- 8.15.2 Financials
- 8.15.3 Product Portfolio
- 8.15.4 Business Strategy
- 8.15.5 Recent Developments
- 8.1 LifeSign LLC
List Of Figures
Figures No 1 to 20
List Of Tables
Tables No 1 to 52
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2030
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Key Players
- LifeSign LLC
- Medtronic plc
- Nano-Ditech Corporation
- Nexus Dx Inc.
- PTS Diagnostics
- Bio-Rad Laboratories Inc.
- Hoffmann-La Roche AG
- Nova Biomedical Corporation
- Trividia Health Inc.
- Sekisui Diagnostics
- Nipro Corp.
- Trinity Biotech
- Orasure Technologies, Inc.
- Spectral Medical Inc.
- Others
FAQs
“Asia-Pacific” region will lead the global Cardiac POC Testing market during the forecast period 2022 to 2030.
The key factors driving the market are Use Of Cardiac POC Testing In Hospitals And Laboratories, Increasing Heart-Related Disorders, Increases The Overall Potential Sale Of POC Testing
The key players operating in the Cardiac POC Testing market are LifeSign LLC, Medtronic plc, Nano-Ditech Corporation, Nexus Dx Inc., PTS Diagnostics, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Nova Biomedical Corporation, Trividia Health Inc., Sekisui Diagnostics, Nipro Corp., Trinity Biotech, Orasure Technologies, Inc., Spectral Medical Inc.
The global Cardiac POC Testing market is expanding growth with a CAGR of approximately 6.5% during the forecast period (2022 to 2030).
The global Cardiac POC Testing market size was valued at USD 1.2 Billion in 2021 and it is projected to reach around USD 2.89 Billion by 2030.